Volitionrx (VNRX) Non-Current Debt (2017 - 2025)
Volitionrx (VNRX) posted Non-Current Debt of $5.8 million for Q4 2025, up 4.54% on a QoQ basis from $5.6 million in Q3 2025, and up 47.19% year-over-year from $4.0 million in Q4 2024.
Volitionrx (VNRX) Non-Current Debt (2017 - 2025) Analysis & Trends
Volitionrx's Non-Current Debt history runs 9 years deep, the most recent figure standing at $5.8 million for Q4 2025.
- Quarterly Non-Current Debt rose 47.19% year-over-year to $5.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5.8 million (up 47.19% YoY) and the FY2025 annual result came in at $5.8 million, up 47.19% from the prior year.
- Non-Current Debt was $5.8 million for Q4 2025 at Volitionrx, up from $5.6 million in the prior quarter.
- Across five years, Non-Current Debt topped out at $6.8 million in Q2 2025 and bottomed at $1.7 million in Q2 2022.
- A 5-year average of $3.6 million and a median of $3.4 million in 2024 frame the typical range for Non-Current Debt.
- Annual changes were most pronounced in 2022 — Non-Current Debt sank 42.7% — and 2024, when it jumped 130.23%.
- Volitionrx's Non-Current Debt stood at $2.3 million in 2021, then rose by 22.39% to $2.8 million in 2022, then jumped by 30.43% to $3.6 million in 2023, then climbed by 9.05% to $4.0 million in 2024, then jumped by 47.19% to $5.8 million in 2025.
- Business Quant data shows VNRX's Non-Current Debt at $5.8 million in Q4 2025, $5.6 million in Q3 2025, and $6.8 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.88 Bn | 176.59 Bn | 6.27 Bn | 29.64 Bn |
| 2 | Stryker | 128.95 Bn | 126.07 Bn | 3.81 Bn | 14.22 Bn |
| 3 | Medtronic | 108.68 Bn | 99.46 Bn | 6.41 Bn | 26.17 Bn |
| 4 | Boston Scientific | 68.54 Bn | 67.09 Bn | 3.61 Bn | 10.99 Bn |
| 5 | Edwards Lifesciences | 48.26 Bn | 44.58 Bn | 1.29 Bn | 598.50 Mn |
| 6 | Dexcom | 28.39 Bn | 27.28 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.22 Bn | 25.93 Bn | 1.98 Bn | 10.13 Bn |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | 3.18 Bn |
| 9 | Koninklijke Philips | 24.66 Bn | 21.54 Bn | 2.07 Bn | 8.07 Bn |
| 10 | Volitionrx | 89,535.16 | -1.03 Mn | - | 5.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.82 Mn |
| Sep 30, 2025 | 5.57 Mn |
| Jun 30, 2025 | 6.79 Mn |
| Mar 31, 2025 | 6.39 Mn |
| Dec 31, 2024 | 3.95 Mn |
| Sep 30, 2024 | 4.80 Mn |
| Jun 30, 2024 | 3.87 Mn |
| Mar 31, 2024 | 3.37 Mn |
| Dec 31, 2023 | 3.62 Mn |
| Sep 30, 2023 | 2.09 Mn |
| Jun 30, 2023 | 3.65 Mn |
| Mar 31, 2023 | 2.55 Mn |
| Dec 31, 2022 | 2.78 Mn |
| Sep 30, 2022 | 2.28 Mn |
| Jun 30, 2022 | 1.74 Mn |
| Mar 31, 2022 | 2.03 Mn |
| Dec 31, 2021 | 2.27 Mn |
| Sep 30, 2021 | 2.03 Mn |
| Jun 30, 2021 | 3.04 Mn |
| Dec 31, 2020 | 2.61 Mn |